End-of-Life Care - Preferences of Patients with Advanced Urological Carcinoma

• Conditions: C61; C67; Malignant neoplasm of prostate; Malignant neoplasm of bladder

• Registration Number: DRKS00025957
• Lead Sponsor: Klinik für Anästhesie und Intensivmedizin Universitätsklinikum Gießen und Marburg, Standort Marburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-20
• Study Completion: 2021-12-01
• Results First Posted: 2024-01-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Patients with metastatic or irresectable prostate cancer, urothelial cancer, or renal cell carcinoma
- Age = 18 years
- Ability to give consent
- Sufficient knowledge of German to participate in the survey

Exclusion Criteria

- Patients with lower tumor stages than indicated above
- Age <18 years
- Not able to give consent
- Insufficient knowledge of German

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Recording of the preferences regarding the place of death of people with advanced urological cancer entities<br>- Recording of the existence of a living will or power of attorney<br>- Investigation of the influence of disease-related factors on the desired place of death of people with advanced urological carcinoma

Secondary Outcome Measures

Name	Time	Method
- To what extent do patients with advanced urological cancer know the stage of their disease<br>- Do the patients wish to have discussions about further care planning?<br>- Does the preference of the place of death change as the disease / metastasis worsens? Is there a connection between the desire to die and, for example, stressful symptoms?